Pharma Journalist -

U.S.-based multi platform gene therapy company pronounces completion of merger with Inotek pharmaceuticals that looks to combat rare diseases. The inclusive company to emphasize on…
Read More...

In a bid to replace its expired base shelf prospectus and corresponding shelf registration statement on form F-10, Aurinia Pharmaceuticals files new tentative base shelf prospectus …
Read More...

Committed to developing and commercialising products to cure rare diseases proclaims granting US patent entitled Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis.…
Read More...

PharmaMar enters into a distribution license agreement with Megapharm for the commercialisation of anticancer drug Aplidin (plitidepsin) in Israel derived from marine. As per the…
Read More...

Indivior declares collaboration with Addex Pharma to accelerate GABAB positive allosteric modulators (PAMs). It has previously recorded preclinical efficacy in animal models for alcohol…
Read More...

Taiwan and US based biopharmaceutical company, Foresee pharmaceutical Co., Ltd. ventures into an exclusive license and distribution agreement with an Israel based biopharmaceutical…
Read More...

U.S FDA has accepted the IND application for ASN007, a selective ERK ½ inhibitor as declared by Asana BioSciences which specialises in oncology nd a clinical stage biopharmaceutical…
Read More...

Genecentric Therapeutics Inc. Proclaimed a research collaboration to assess the potential of Genecentric’s Cancer Subtype Platform in order to detect responders to G1 Therapeutic’s oral…
Read More...

Novaquest Capital Management announced acquisition of Viamet Pharmaceuticals including the company’s product candidate, VT-1161 that successfully complete phase 2b clinical trials for…
Read More...

ArunA Biomedical officially launches of a new class exosome biologics to cure central nervous system and neurogenerative disorders. The company published conclusions of a study…
Read More...